CROSARA, Serena
 Distribuzione geografica
Continente #
EU - Europa 798
NA - Nord America 781
AS - Asia 340
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.922
Nazione #
US - Stati Uniti d'America 771
CN - Cina 237
IE - Irlanda 215
IT - Italia 184
SE - Svezia 156
TR - Turchia 62
FI - Finlandia 59
AT - Austria 51
DE - Germania 48
BE - Belgio 30
IR - Iran 19
FR - Francia 13
UA - Ucraina 12
GB - Regno Unito 9
IN - India 9
TW - Taiwan 6
HU - Ungheria 5
NL - Olanda 5
CA - Canada 4
MX - Messico 4
CH - Svizzera 3
JP - Giappone 3
EE - Estonia 2
HN - Honduras 2
NO - Norvegia 2
QA - Qatar 2
A1 - Anonimo 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
MK - Macedonia 1
PE - Perù 1
RO - Romania 1
SG - Singapore 1
Totale 1.922
Città #
Dublin 215
Chandler 208
Ann Arbor 99
Beijing 65
Izmir 60
Dearborn 56
Nanjing 45
Vienna 41
Parma 37
Princeton 36
Brussels 29
Wilmington 25
Bremen 21
Shenyang 18
Kunming 14
Hebei 12
Sant'ilario D'enza 12
Fremont 11
Mountain View 11
San Mateo 11
Jacksonville 10
Woodbridge 10
Changsha 9
Nanchang 9
Zanjan 9
Helsinki 8
Jinan 8
Jiaxing 7
Brescia 6
Des Moines 6
Hefei 6
Ningbo 6
Pignone 6
Washington 6
Abano Terme 5
Milan 5
Monza 5
Zhengzhou 5
Chengdu 4
Düsseldorf 4
Falls Church 4
Guangzhou 4
Hangzhou 4
Sassuolo 4
Verona 4
Bari 3
Boardman 3
Chieti 3
Genoa 3
Haikou 3
Leawood 3
Los Angeles 3
Magenta 3
Mexico City 3
Mumbai 3
New Taipei 3
Norwalk 3
Sacramento 3
Tianjin 3
Tokyo 3
Vaiano Cremasco 3
Vicopisano 3
Wake Forest 3
Ashburn 2
Berlin 2
Borås 2
Casanova Lonati 2
Catania 2
Doha 2
Fairfield 2
Frankfurt am Main 2
Fuzhou 2
Giessen 2
Hanover 2
Houston 2
Lodi 2
Montreal 2
Nonantola 2
Oslo 2
Paderno Dugnano 2
Padova 2
Palermo 2
Pingtung City 2
Reggio Emilia 2
Reggio Nell'emilia 2
Rocklin 2
Rockville 2
Tallinn 2
Toronto 2
Wuhan 2
Zurich 2
Aarle-Rixtel 1
Amsterdam 1
Andover 1
Auburn Hills 1
Blacksburg 1
Bologna 1
Brno 1
Budapest 1
Bursa 1
Totale 1.299
Nome #
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs 145
Normal aortic annulus dimensions in Boxer dogs according to sex and body weight 119
Aorto-septal angle, isolated basal septal hypertrophy and systolic murmurs in 122 cats 108
Transthoracic echocardiography in clinically healthy adult Newfoundland dogs: reference values for the breed 88
Systolic Arterial Pressure Measured Simultaneously by Doppler Technique, Using Forelimb and Hindlimb in Dogs 85
Tetralogia di Fallot in un gatto 79
Aorto-septal angle and systolic murmur in apparently healthy cats: a pilot study 77
Migration of a Kirschner wire to the heart in a Yorkshire terrier 65
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study 57
ECG of the month 54
Anatomic distribution and electrophysiologic properties of accessory atrioventricular pathways in dogs 48
Screening for subaortic stenosis in Boxers in Italy 48
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study 47
Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease 46
La malattia valvolare mitralica nel cane 45
Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease 45
Miocardiopatie del cane 44
Endocardite batterica 44
Corner Diagnostico di Cardiologia 44
Holter monitoring in 36 dogs with myxomatous mitral valve disease 43
Insufficienza cardiaca: fisiopatologia e principi di terapia 43
Diagnostic performance of P wave duration in the identification of left atrial enlargement in dogs 43
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 42
Systolic arterial pressure measured simultaneously by Doppler technique, using forelimb and hindlimb, in dogs 41
Radiofrequency catheter ablation of concealed accessory pathways in two dogs with symptomatic atrioventricular reciprocating tachycardia 41
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 39
Malattia cronica mitralica 38
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease 37
Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration 36
The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics 35
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 34
Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease 34
The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics 33
Use of contrast echocardiography for quantitative and qualitative evaluation of myocardial perfusion and pulmonary transit time in healthy dogs 32
Utility of 12-Lead Electrocardiogram for Differentiating Paroxysmal Supraventricular Tachycardias in Dogs 31
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease 29
Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs 26
Holter monitoring in dogs with mitral regurgitation and different class of heart failure 21
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease 17
Suspected Drinking Water Poisoning in a Domestic Kitten with Methemoglobinemia 5
Aorto-septal angle, isolated basal septal hypertrophy, and systolic murmur in 122 cats 3
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 2
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 1
Totale 1.994
Categoria #
all - tutte 5.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019101 0 0 0 2 10 5 1 2 4 2 68 7
2019/2020389 73 75 17 9 16 55 34 22 18 59 8 3
2020/2021135 3 6 8 4 23 12 4 14 31 17 7 6
2021/2022239 34 5 6 14 13 5 7 25 10 15 32 73
2022/2023891 68 84 62 68 70 90 19 67 284 25 28 26
2023/202488 32 35 21 0 0 0 0 0 0 0 0 0
Totale 1.994